December 05, 2025 – ETCTN
CTEP is accepting Letters of Intent (LOIs) to conduct clinical studies using epcoritamab (EPCOR), a bispecific cluster of differentiation (CD)20-directed CD3 T-cell engager, which is being developed by CTEP as an…
DF/HCC Is a Research Consortium
that provides shared resources and a collaborative environment for over 1,100 cancer researchers at 7 Harvard institutions. Learn more about DF/HCC here
Information for DF/HCC members and collaborators
Shared resources available to DF/HCC members
Resources and initiatives for Massachusetts communities
Opportunities for training and career enhancement
Research Funding Opportunities